Search results for "From ACP Journal Club"
Neither n-3 fatty acid supplements nor glargine reduced CV events in patients with dysglycemia
The Outcome Reduction with an Initial Glargine Intervention trial randomized about 12,000 patients with cardiovascular risk factors and dysglycemia to basal insulin glargine or usual care and daily n-3 fatty acid supplementation or olive oil placebo.
https://diabetes.acponline.org/archives/2012/10/12/8.htm
12 Oct 2012
Mediterranean diets reduced cardiovascular events more than a low-fat diet in high-risk persons
A randomized controlled trial (RCT) in Spain included older patients with type 2 diabetes mellitus or at least three major risk factors for cardiovascular disease.
https://diabetes.acponline.org/archives/2013/07/12/7.htm
12 Jul 2013
Safety of dipeptidyl peptidase-4 inhibitors analyzed in 2 studies
A meta-analysis of dipeptidyl peptidase-4 inhibitors showed no increase in pancreatic adverse events, while a trial of saxagliptin found no effect on the overall rate of cardiovascular events.
https://diabetes.acponline.org/archives/2014/02/14/7.htm
14 Feb 2014